VC-Verzeichnis

Seed VC-Firmen Verzeichnis

Kuratierter Index aktiver Venture-Capital-Fonds in Europa und Israel. Verfolge Investoren, Phasen und Ticketgrößen.

Climate VC

Europa

Climate VC is a venture capital firm investing in pre-seed and seed stage climate startups with the goal of decarbonizing the economy and our lives. They focus on funding elite founding teams building solutions to address the climate crisis, aiming for a gigatonne-scale impact. The firm recognizes the climate crisis as both the greatest threat and the greatest opportunity to shape civilization. They aim to ignite the early spark of innovative solutions across various sectors, including food, transportation, electricity generation, and manufacturing.

Pre-seed, SeedCarbon RemovalsClimate Finance Data

CoVentures

BE

Co Ventures is a pre-seed fund focused on backing Australian founders building software-led companies with global ambitions from day one. They aim to provide belief, networks, and infrastructure to transform early-stage ambition into tangible results. The firm recognizes that traditional venture capital often favors familiar patterns and overlooks unconventional ideas or founders who don't fit established molds. Co Ventures seeks to address this by intentionally supporting founders with the grit, clarity, and ambition to build global companies, even when ideas are raw and markets are undefined. They are focused on edge cases and quiet convictions.

Pre-seedSoftware

Columbus Venture Partners

Valencia, ES

Columbus Venture Partners drives life-changing biotechnology that transforms lives and generates solid returns by investing in therapeutic and industrial products through life science funds. They focus on therapeutic innovation, combining therapeutic seed funding with infrastructure creation to build complete value chains and shorten return timelines. They prioritize profitability as a consequence of healthcare developments. They design exit strategies before investing to maximize capital and offer a lower fee structure compared to other funds. They aim to democratize access to gene therapy, both in volume and speed of production, while also reducing manufacturing costs.

SeedTherapeutic productsIndustrial products

Connect Ventures

London, Großbritannien

Connect Ventures focuses on backing exceptional founders building outlier product companies. The firm emphasizes a product-centric approach, prioritizing companies with strong developer experience and a deep understanding of their users' needs. They aim to be more than just investors, positioning themselves as long-term partners who understand the intricacies of building product-led businesses. They seek founders building solutions to problems they personally experience, leading to innovative products that resonate with a wider audience. Connect Ventures looks for companies where they can establish a high level of trust and alignment with the founders, acting as a sounding board and accountability partner throughout their journey. The firm's investment strategy is to lead or co-lead pre-seed and seed rounds, providing crucial early-stage funding and support. They understand the importance of product development and community-led growth, particularly in areas like marketplaces, market networks, and networked SaaS. The partners have experience as founders themselves, providing firsthand understanding of the challenges and opportunities that startups face. The firm actively supports their portfolio companies with fundraising strategies and leadership development. Connect Ventures places high importance on the founder's journey and their ability to create impactful products. The quotes from portfolio founders highlight Connect's understanding of product, commitment through thick and thin, and willingness to be hands-on when needed. Their investment decisions are driven by a belief in the power of product to drive growth and category domination, and they actively experiment with new frameworks like Minimum Viable Category Design to help their portfolio companies succeed.

Pre-Seed, SeedAIDeep Tech

Counterview Capital

New York, USA
C

Counterview Capital is a New York-based venture capital firm that focuses on pre-seed and seed stage technology companies. They aim to partner with creative and unconventional thinkers who are building innovative products intended to change the world. The firm has a "counter view" towards venture capital, and they seek founders who similarly challenge the status quo.

Pre-seed, SeedTechnology

Cryptology Asset Group

LU

Samara Asset Group focuses on seeding emerging managers and builders in the decentralized finance and technology space. Their mission revolves around democratizing investing and fostering the growth of innovative companies. They aim to provide capital, strength, and guidance to companies building the future of finance, which they believe is decentralized and empowered by Bitcoin and emerging technologies. They are a publicly listed company that also holds Bitcoin.

Seeding emerging managersBitcoinDecentralized Finance

DHS Venture Partners

Stockholm, Schweden

DHS Venture Partners is a venture capital firm comprised of Stockholm School of Economics alumni, including founders, investors, operators, and angels. They focus on supporting the next generation of great entrepreneurs by co-investing in early-stage companies. Their investment strategy centers around backing founders with innovative ideas that have the potential to scale into lasting businesses. DHS Venture Partners frequently acts as the first investor in their portfolio companies, providing ongoing support throughout their growth journeys. The firm's unique approach combines the expertise, proximity, and deep domain insight of an angel investor with the network, resources, and strength of an experienced community. With 25 selected venture partners and an active alumni group, DHS Venture Partners provides founders with access to a broad range of skills and connections. This collaborative model allows them to offer comprehensive support and guidance, increasing the chances of success for their portfolio companies. Based on portfolio data, DHS Venture Partners concentrates on pre-seed and seed stage investments. Their investment strategy is particularly focused on companies located in Sweden. By investing early and providing significant value-add through their network and expertise, DHS Venture Partners aims to build long-term relationships with founders and contribute to the growth of a vibrant entrepreneurial ecosystem.

Pre-seed, SeedAIClimate

Daring Capital

Großbritannien

Daring Capital invests in extraordinary underrepresented founders building companies that make the world a better place. They focus on mission-led startups often overlooked by traditional investors due to lack of track record or access to wealthy networks. The firm emphasizes transparency, agility, and founder-centric support to drive impact and profitability.

Early-stage (pre-seed to seed)Early-stage companies founded by underrepresented individuals solving real-world problemswith a focus on social impact and mission-driven innovation.

DeBa Ventures

Luxembourg, LU
D

DeBa Ventures is a venture capital firm focused on discovering, supporting, and promoting founders crafting the future of fintech. They are more than just investors; they aim to be partners in shaping the future of the fintech industry by seeking out passionate entrepreneurs solving real-world problems through innovation. The firm emphasizes a founder-driven approach, leveraging the experience of their team, which includes successful exited entrepreneurs and seasoned fund managers. They provide tailored mentorship and strategic support, recognizing the unique challenges startups face. DeBa Ventures offers flexible investment models and fosters a collaborative partnership through their network of experts and advisors, combined with regular strategic sessions. Their investment strategy is global and prioritizes fintech companies, along with B2B, AI and SaaS, reflecting a commitment to fostering innovation in these dynamic sectors without geographical limitations. They believe in nurturing innovation and building a collaborative journey with visionary founders. The firm's mission is to uncover, nurture, and elevate the entrepreneurs shaping the future. DeBa Ventures distinguishes itself with a unique shared success model, allocating 10% of their profits back to the employees of their portfolio companies, acknowledging their contributions to collective achievements and growth. This policy reflects their belief in rewarding dedication and hard work, creating a mutually beneficial partnership. They measure their achievements by the great entrepreneurs they partner with, highlighting their portfolio's forward-looking companies.

Pre-seed, Seed, GrowthFintechB2B

Debiopharm Innovation Fund

Lausanne, CH

Debiopharm Innovation Fund invests in digital health and smart data start-ups with the aim to improve patient outcomes and quality of life, particularly in oncology and infectious diseases. They seek to establish tomorrow's standard of care by enabling innovation in drug development, drug manufacturing, and digital health. The fund focuses on companies applying AI and data-driven insights to accelerate clinical trials, improve patient outcomes, and enhance drug discovery. They aim to leverage new imaging digital biomarkers from longitudinal images to help Debiopharm accelerate time to market and improve success rates of clinical trials, and are exploring digital twins for use in virtual control arms. The fund invests in areas that can significantly reduce the time and costs of clinical trials, more accurately predict patient outcomes, or enhance drug discovery using AI and data analytics. They are interested in platforms that can acquire imaging data from trial sites and generate clinically meaningful predictions from imaging data. Additionally, they seek opportunities in areas like collaborative software platforms for expanded access to medicines, cancer data aggregation and analytics platforms for precision oncology, and privacy-preserving data collaboration platforms. Debiopharm's investment strategy is driven by a desire to positively contribute to society and the environment through corporate responsibility. The fund supports projects and works that aim at improving the quality of life for patients. They actively seek out entrepreneurs with ambitions to take their professional endeavors to the next level and provide funding and support to help them achieve their goals. They appear to be interested in solutions related to in-vivo study design, AI-driven data cleaning, precision medicine in radiology, AI for clinical teams and multimodal AI models for histology images.

Not explicitly mentioned, but appears to target seed and early-stage companies.Digital HealthAI

Deepbridge Capital

Chester, Großbritannien

Deepbridge Capital aims to redefine the growth capital market by providing investors with access to opportunities in technology, life sciences, and renewable energy sectors, sourced, reviewed, and managed by their team of sector specialists. They focus on supporting energetic, passionate, and knowledgeable management teams to help their businesses achieve their full potential and provide optimum returns for investors. Deepbridge offers various investment products, including EIS and SEIS funds, catering to different risk profiles and investment goals. The firm places emphasis on understanding the operational aspects of investee companies to effectively support, mentor, and manage those businesses through their funding journey, from seed stage through commercialization and growth funding. Deepbridge uses a rigorous investment process, including a Supervisory Investment Committee which provides oversight on the technical and commercial elements of proposed and executed investments. This committee, comprised of Deepbridge executives and independent experts, ensures investments align with the mandate of their products and services. They emphasize a culture of professional excellence and integrity, encouraging investee companies to achieve the highest standards of corporate governance. They aim to mitigate risk through deep due diligence, sectoral expertise, and active management. They offer the FlexEIS, a revolutionary approach enabling financial advisers to recommend investments in the Deepbridge Life Sciences EIS and Deepbridge Technology Growth EIS funds, aligning growth-focused venture capital with regular financial planning. This method allows investors to benefit from the tax reliefs of the Enterprise Investment Scheme (EIS) on an ongoing basis, rather than through traditional annual lump sum commitments, starting from £1,000 per month per fund. The firm also offers the Private Investor Network enabling experienced investors to define their own portfolio of innovative Life Sciences and Technology companies. Tax benefits are a key component of Deepbridge's investment offerings. They highlight the potential for 30% income tax relief, capital gains tax deferral, no capital gains tax on disposal of shares held for at least three years, inheritance tax exemption, and loss relief. They actively use the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) to provide tax advantages to investors. Deepbridge manages various products based on SEIS and EIS criteria, providing opportunities to participate in portfolios of seed-stage technology innovation companies, growth-focused technology companies, and healthcare innovation companies, while taking advantage of potential tax benefits.

Seed stage, Commercialization, Growth fundingTechnologyLife Sciences

Deepbridge Capital LLP

Chester, Großbritannien

Deepbridge Capital is a growth capital specialist focusing on the technology, life sciences, and renewable energy sectors. They aim to provide investors with tax-efficient investment opportunities by leveraging the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS). Their investment strategy involves supporting energetic, high-performance management teams and working with investee companies throughout their funding journey, from seed stage through commercialization and growth funding. This hands-on approach ensures investee companies have the best opportunity to succeed and provides investors with an optimum return.

Seed, Commercialisation, GrowthTechnologyLife Sciences

Delphinus Venture Capital

Aarhus, DK
D

Delphinus Venture Capital is an evergreen fund investing in research-based businesses from pre-seed through Series B, focusing on sectors like Food, Health, Defence, and Energy. They prioritize transparency, long-term partnership, and founder-centric support with a lean structure to move quickly and respect founders' time.

Pre-seed to Series BResearch-based businesses solving real-world challenges

Demium Capital

Madrid, ES

We invest in talent. We invest in the earliest stages of a startup –pre-seed and seed stages–, when the co-founding team has already validated their business plan.

Early StageWe invest in talent. We invest in the earliest stages of a startup –pre-seed and seed stages–when the co-founding team has already validated their business plan.

Deuce Capital

London, Großbritannien
D

Deuce Capital invests in pre-seed and seed stage HealthTech businesses based in the United Kingdom. They bring operator experience and network to mentor founders, and help them turn their visions into scalable, impactful businesses.

SeedHealthTech

Digital Ocean Ventures Starter

Warsaw, PL

Digital Ocean Ventures Starter (DOV.VC) focuses on backing early-stage fintech and digital transformation startups, especially those leveraging AI. They seek to invest in companies that are designed for the venture path, exhibiting sharp insights, unfair distribution advantages, or defensible data that compounds over time. They prioritize understanding the founders, the customer pain points, and the business logic under pressure before making an investment. Recognizing that not every good business is suited for venture capital, they exercise selectivity. When they invest, DOV.VC commits time and attention alongside capital, acting as partners and providing skin in the game. DOV.VC believes that venture capital should genuinely help build better companies. They emphasize understanding over speed, opting to spend more time upfront evaluating the people, the problem being solved, and the scalability of the business model. They are comfortable saying no to businesses that might be good but not venture-scalable, focusing on where their capital, time, and partnership can accelerate long-term value creation. They consider themselves partners rather than just capital providers and offer hands-on support to founders through both favorable and challenging periods. This high-touch approach involves significant involvement, attention, and commitment, emphasizing a deep trust and belief in the companies they support. They invest in people they'd want to work with, focusing on real-world problems and businesses with enduring, scalable systems.

Pre-seed, SeedFintechDigital Transformation

Draper Venture Partners

San Mateo, USA

Draper Associates is a global venture capital firm that invests in world-shaping companies. They back bold founders with transformative ideas, technologies, and industries that will define the next century. The firm invests early, from pre-seed to Series A, across all sectors and geographies, focusing particularly on frontier industries. They combine deep technical expertise with extensive operational experience to help founders navigate the challenges of scaling breakthrough technologies. Draper Associates provides strategic guidance, network access, and conviction derived from four decades of experience backing category-defining companies. They aim to turn science fiction into reality, one bold investment at a time, supporting entrepreneurs shaping tomorrow's economy.

Pre-seed, Seed, Series AAIRobotics & Automation

EF

London, Großbritannien

Entrepreneurs First (EF) is a venture capital firm that invests in individuals *before* they have a company or even a fully formed idea. Their core thesis revolves around identifying exceptionally talented individuals, often from academic institutions and tech communities, and providing them with the resources, network, and support necessary to find a co-founder, develop a viable business idea, and ultimately build a globally ambitious company. EF aims to liberate talented individuals from traditional career paths by reframing what’s possible and enabling them to make an impact sooner rather than later. They believe that *who* starts companies is just as important as *which* companies get started. EF's approach involves building cohorts of exceptional peers and providing access to expert advisors and a specialized network, which would otherwise be difficult to obtain. They offer a unique matching process to help individuals find optimal co-founders, weekend residential retreats to kickstart the founding journey, and hands-on support to shape ideas and navigate the US market. EF actively facilitates transformative cofounding relationships, not merely productive ones. The firm's program includes workshops on customer development for the US market, office space in San Francisco, and Demo Days attended by top-tier VCs. EF acts as a bridge connecting global talent to the Silicon Valley ecosystem, offering support in areas such as visa acquisition and access to venture capital. Their support extends from the initial coffee meeting to the company's exit, with talent investors playing a crucial role in identifying, advising, and fundraising for founders. They help founders grow and scale to become significant venture-backed startups. EF seeks individuals who are intellectually curious, innately driven, strong network builders, discerning judges of people, and excited by the role of technology. EF's investment strategy also includes providing dedicated advisors on the ground to help shape ideas and San Francisco-based partners to help crack the U.S. market. By Demo Day, EF expects top performing founders to be generating hundreds of thousands of revenue. The firm aims to accelerate the path to building a world-class company for the founders they back. EF distinguishes itself by investing in talent before it is obvious to others, and nurturing that talent to build impactful companies.

Pre-seed, SeedAIB2B

EMV Capital

Großbritannien

EMV Capital is a deep tech and life sciences venture capital investment group focused on generating superior returns for investors by investing in, managing, and strengthening early-stage IP-rich companies. They target fast-growing sectors and technologies that will define the future. Their approach is characterized by proactive management to advance companies to critical value inflection points and a capital-efficient investment model that utilizes the PLC balance sheet and syndicate investments. EMV Capital has an evergreen structure that supports extensive growth and value creation through direct equity stakes, carried interest in portfolio companies, and the management of independent third-party funds.

Early Stage, Pre-seed, SeedSustainabilityLife Sciences

Empirical Ventures

Großbritannien

Empirical Ventures is a specialist VC and venture builder focused on backing early-stage, deep-tech ventures in Europe. They bridge the gap between groundbreaking scientific discoveries and the resources needed to bring them to life. The firm invests in scientific breakthroughs that advance human capability and create financial returns, targeting solutions to global challenges while disrupting existing markets. Empirical Ventures brings together deep scientific expertise, entrepreneurial vision, and financial backing to turn ideas into transformative ventures. Their team possesses the skills to understand the science and scale businesses for long-term success. They offer portfolio exposure to deep science investments supported by a robust due diligence process conducted by experienced entrepreneurs, operators, investors, and scientists, de-risking investments for co-investors.

Pre-seed, SeedLife SciencesAdvanced Materials

Enjoyventure Management

Deutschland

EnjoyVenture GmbH is a venture capital firm that invests in innovative business models with the potential to influence the market and reform established business models. They are passionate about tech-affine startups and businesses with whom they want to discover new trends and shape the future. With over 20 years of experience since 2000, they expertly support technology startups. EnjoyVenture emphasizes talent investment, extensive networking within investor and technology sectors, and an interdisciplinary team with many years of business experience. They aim to connect innovative business models to the future through experience, networks, and investment strategies, leading innovations and teams to success. They focus on partnering with companies showing potential to influence markets. They support companies in their early stage from seed stage and on. They focus on supporting the company to grow within the market.

Early Stage, Start-upsTechnologyInnovative Business Models

Entree Capital

Tel Aviv, IL

Entrée Capital is a venture capital firm managing $1.5 billion across multiple funds with offices in Tel Aviv, London, and New York. Their investment philosophy centers around partnering with exceptional founders to build impactful companies addressing significant challenges. They focus on early-stage investments (pre-seed, seed, and Series A) across Israel, the UK, Europe, and the United States. The firm aims to back founders who are building the impossible, particularly in areas such as AI, Deep-Tech, Crypto, and innovative B2B solutions. Entrée Capital is adapting to the changing landscape of the software industry, acknowledging the shift from Systems of Record (SOR) to Systems of Context, where AI-driven solutions that understand the nuances of business goals and historical data are becoming increasingly valuable. The firm is focused on investing in AI-native companies that can leverage data to improve their products iteratively and deliver significant value to users. The firm's investment strategy also includes a contrarian approach, focusing on verticals that others might overlook due to smaller software budgets. They believe that AI can unlock significant opportunities in these industries, driving complete resets and unlocking P&L potential. They are keenly observing AI agents, decentralized platforms, and web3 security. They seek companies that can bridge the gap between organizing and completing work, with autonomous agents that own the context of the user. Entrée Capital emphasizes the importance of founder DNA and is committed to supporting entrepreneurs from the earliest stages. The firm aims to build enduring companies by providing unwavering support and resources to exceptional founders. The firm also understands the importance of leveraging the AI revolution and is focused on backing companies that are at the forefront of this transformative technology.

Pre-seed, Seed, Series AArtificial Intelligence (AI-native applicationsvertical AI

Entrée Capital

London, Großbritannien

Entrée Capital is a venture capital firm managing $1.5 billion across several funds, with offices in Tel Aviv, London, and New York. They focus on partnering with exceptional founders to build innovative companies addressing meaningful challenges. Their investment strategy targets early-stage investments, specifically pre-seed, seed, and Series A rounds, across Israel, the UK, Europe, and the US. The firm seeks companies in AI, Deep-Tech & Quantum Computing, Software, Data & B2B Productivity, Crypto infrastructure and security, and "Weird Is Wonderful" frontier innovation. Entrée Capital aims to invest in companies that are building the impossible and disrupting traditional industries. The firm emphasizes a founder-centric approach, standing with entrepreneurs from day zero and supporting them throughout their journey. They prioritize companies demonstrating strong product-market fit, data-driven decision-making, and the potential for significant impact. The firm believes that AI is a foundational transformation of the global economy and focuses on AI-native founders building vertical agents, infrastructure, and category-defining software. They also recognize the convergence of physics, compute, software, and national-security innovation. Entrée Capital is particularly interested in verticals often overlooked due to smaller software budgets but ripe for disruption through AI-driven solutions. They are proactive about engaging with potential portfolio companies, showcasing examples of direct outreach and early engagement that led to customer adoption and, eventually, investment. They appear to value companies that create systems of context, move beyond simply organizing work, and embrace autonomous agents capable of completing tasks, differentiating themselves from systems of record.

Pre-seed, Seed, Series AArtificial IntelligenceDeep-Tech & Quantum Computing

EquiFund

GR
E

EquiFund is a fund-of-funds program in Greece designed to strengthen the venture capital market and provide crucial financing to SMEs. Recognizing the historically low levels of venture capital and private equity activity in Greece compared to the rest of the EU, EquiFund aims to address the equity financing needs of SMEs to foster growth and job creation. The program makes commitments in professionally and independently managed funds, which in turn invest in Greek businesses. EquiFund is an initiative created by the Hellenic Republic in cooperation with the European Investment Fund (EIF), which also acts as an independent advisor. The program is co-financed by the EU and national funds, as well as funding from the EIF. The European Investment Bank and strategic partners such as the Onassis Foundation and the National Bank of Greece have also committed to several of the EquiFund-supported funds. Ultimately, EquiFund aims to unlock the social and economic wealth creation potential of talented individuals in Greece and its diaspora.

Pre-seed, Seed, Series A, GrowthTechnology segments such as softwaredata analytics